Willingness to participate and take risks in HIV cure research: survey results from 400 people living with HIV in the US

Introduction: Participation in early-phase HIV cure studies includes clinical risks with little to no likelihood of clinical benefit. Examining the willingness of people living with HIV to participate is important to guide study design and informed consent. Our study examined the overall willingness...

Full description

Bibliographic Details
Main Authors: Karine Dubé, David Evans, Laurie Sylla, Jeff Taylor, Bryan J. Weiner, Asheley Skinner, Harsha Thirumurthy, Joseph D. Tucker, Stuart Rennie, Sandra B. Greene
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:Journal of Virus Eradication
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2055664020302958